Is a PET-CT Scan Useful for — Cancer Screening in a Healthy Person?

Detecting cancer and being a good screening test are two different things. A screening test must reliably find cancer early, produce very few false alarms, and improve outcomes across a whole population — all proven before it becomes standard practice. PET-CT has not met that standard for healthy people. It detects abnormal metabolic activity, which cancer produces, but so do infection, inflammation, and several normal organs. That ambiguity is manageable when tracking a known cancer; it creates a cascade of unnecessary investigations when applied to someone with no symptoms.

You can, but clinical guidance consistently advises against it, and this is important to understand before you spend the money. A private scan in a healthy person is just as likely to generate incidental findings — unexpected results that require more tests, sometimes including biopsy, to rule out — as one ordered for a medical reason. A clear scan also does not mean you are cancer-free, because PET-CT can miss small early tumours. Before booking any scan as a health check, a conversation with a doctor about which evidence-based screening tests genuinely apply to your age and risk profile will give you more useful information.

Not necessarily. PET-CT is ordered for several reasons beyond confirming a new cancer: to stage a cancer that has already been diagnosed, to check how treatment is working, to look for recurrence after treatment has finished, or to investigate a finding from another scan. If you are not sure why it was ordered, ask your doctor directly — they can explain the specific question the scan is intended to answer. Knowing the reason often makes the wait for results considerably less frightening.

There are specific clinical situations where a doctor might order PET-CT before a cancer is confirmed — for example, when lymphoma is suspected, when a biopsy has shown cancer but the primary site is unknown, or when a finding from another investigation needs further characterisation. These are directed clinical decisions based on specific symptoms or results, not routine health checks. The difference between a directed clinical decision and a wellness scan is significant, and it is your doctor who makes that judgement based on what they find when they assess you.

PET-CT involves two sources of radiation: the radioactive tracer and the CT component. The combined dose is meaningful, and it is always weighed by the doctor ordering the scan against the benefit it is expected to provide. For someone with a diagnosed cancer, that balance is usually straightforward — the information the scan provides changes treatment decisions. For a healthy person with no symptoms and no clinical concern, the benefit side of that equation is much weaker. If you have a scan ordered and want to understand the dose involved, ask your nuclear medicine team to explain it.

Start with your personal risk profile: your age, any family history of cancer, whether you smoke, and any symptoms you have noticed. From there, your doctor can tell you which evidence-based screening tests apply to you — whether that is a mammogram, a cervical smear, a colonoscopy, or a low-dose lung CT if you have a long smoking history. Those targeted tests are where the evidence for early detection is strongest. If something specific is worrying you — a lump, unexplained weight loss, blood where it should not be — that is the starting point for a clinical assessment, not a whole-body scan.